Coronary Artery Disease in Very Young Patients: Analysis of Risk Factors and Long-Term Follow-Up – PubMed
Heart disease in young adults
Related Articles
Biomarkers Guide Baked Milk Tolerance in High-Risk Children With Cow’s Milk Allergy
Diagnostic biomarkers can help identify children with cow’s milk allergy who are more likely to tolerate baked milk products safely, new research shows.
Case-based Conference | British Society for Rheumatology
The Rheumatology Case-based Conference brings together consultants and next-generation rheumatologists to share and exchange clinical best practice.
España impulsa la investigación en linfomas con 29 000 casos y 13 ensayos clínicos en curso
Los casos más comunes en España como el linfoma B difuso de células grandes 35 el linfoma folicular 28 y el linfoma de Hodgkin 13…
High-salt diet drives depression-like behavior in mice by inducing IL-17A production
The Editors have selected this article as a highlight of the issue.
Productivity Techniques to Overcome Perfectionism
Although perfectionism is often viewed as a good thing, it can be detrimental to productivity. Here’s how to keep it at bay.
Get With the Guidelines-Heart Failure: Twenty Years in Review, Lessons Learned, and the Road Ahead | Circulation: Heart Failure
The Get With the Guidelines-Heart Failure program was developed in 2005 with the goal of bringing evidence-based guidelines in heart failure management into widespread clinical…
Vivek Subbiah: Enlightening discussions with Dr. Johanna Bendell – OncoDaily
Vivek Subbiah: Enlightening discussions with Dr. Johanna Bendell / cancer, Johanna Bendell, Nashville Sarah Cannon Research Institute, OncoDaily, Oncology,
Simultaneous single-cell sequencing of RNA and DNA at scale with DEFND-seq
Nature Reviews Genetics – In this Tools of the Trade article, Timothy Olsen introduces DEFND-seq, a scalable method for co-sequencing RNA and DNA in single…
Specialty Pharmacy at a Crossroads, Say Attendees at Asembia’s AXS25 Summit
Specialty pharmacy experts and key opinion leaders gathered at Asembia’s AXS25 Summit and discussed critical insights in interviews with Pharmacy Times®.
